期刊文献+

Serum proinflammatory cytokines and nutritional status in pediatric chronic liver disease 被引量:2

Serum proinflammatory cytokines and nutritional status in pediatric chronic liver disease
下载PDF
导出
摘要 AIM: To evaluate the nutritional status and its association with proinflammatory cytokines in children with chronic liver disease.METHODS: We performed a cross-sectional study with 43 children and adolescents, aged 0 to 17 years, diagnosed with chronic liver disease. All patients regularly attended the Pediatric Hepatology Unit and were under nutritional follow up. The exclusion criteria were fever from any etiology at the time of enrollment, inborn errors of the metabolism and any chronic illness. The severity of liver disease was assessed by Child-Pugh, Model for End-stage Liver Disease(MELD) and Pediatric End Stage Liver Disease(PELD) scores. Anthropometric parameters were height/age, body mass index/age and triceps skinfold/age according to World Health Organization standards. The cutoff points for nutritional status were risk of malnutrition(Z-score <-1.00) and malnutrition(Z-score <-2.00). Interleukin-1β(IL-1β), IL-6 and tumor necrosis factor-α levels were assessed by commercial ELISA kits. For multivariate analysis, linear regression was applied to assess the association between cytokine levels, disease severity and nutritional status. RESULTS: The median(25th-75 th centile) age of the study population was 60(17-116)-mo-old, and 53.5% were female. Biliary atresia was the main cause of chronic liver disease(72%). With respect to Child-Pugh score, cirrhotic patients were distributed as follows: 57.1% Child-Pugh A, a mild presentation of the disease, 34.3% Child-Pugh B, a moderate stage of cirrhosis and 8.6% Child-Pugh C, were considered severe cases. PELD and MELD scores were only above the cutoff point in 5 cases. IL-6 values were increased in patients at nutritional risk(34.9%) compared with those who were well-nourished [7.12(0.58-34.23) pg/m L vs 1.63(0.53-3.43) pg/m L; P = 0.02], correlating inversely with triceps skinfold-for-age z-score(rs =-0.61; P < 0.001). IL-6 levels were associated with liver disease severity assessed by Child-Pugh score(P = 0.001). This association remained significant after adjusting for nutritional status in a linear regression model. CONCLUSION: High IL-6 levels were found in children with chronic liver disease at nutritional risk. Inflammatory activity may be related to nutritional status deterioration in these patients. AIM: To evaluate the nutritional status and its association with proinflammatory cytokines in children with chronic liver disease.METHODS: We performed a cross-sectional study with 43 children and adolescents, aged 0 to 17 years, diagnosed with chronic liver disease. All patients regularly attended the Pediatric Hepatology Unit and were under nutritional follow up. The exclusion criteria were fever from any etiology at the time of enrollment, inborn errors of the metabolism and any chronic illness. The severity of liver disease was assessed by Child-Pugh, Model for End-stage Liver Disease(MELD) and Pediatric End Stage Liver Disease(PELD) scores. Anthropometric parameters were height/age, body mass index/age and triceps skinfold/age according to World Health Organization standards. The cutoff points for nutritional status were risk of malnutrition(Z-score <-1.00) and malnutrition(Z-score <-2.00). Interleukin-1β(IL-1β), IL-6 and tumor necrosis factor-α levels were assessed by commercial ELISA kits. For multivariate analysis, linear regression was applied to assess the association between cytokine levels, disease severity and nutritional status. RESULTS: The median(25th-75 th centile) age of the study population was 60(17-116)-mo-old, and 53.5% were female. Biliary atresia was the main cause of chronic liver disease(72%). With respect to Child-Pugh score, cirrhotic patients were distributed as follows: 57.1% Child-Pugh A, a mild presentation of the disease, 34.3% Child-Pugh B, a moderate stage of cirrhosis and 8.6% Child-Pugh C, were considered severe cases. PELD and MELD scores were only above the cutoff point in 5 cases. IL-6 values were increased in patients at nutritional risk(34.9%) compared with those who were well-nourished [7.12(0.58-34.23) pg/m L vs 1.63(0.53-3.43) pg/m L; P = 0.02], correlating inversely with triceps skinfold-for-age z-score(rs =-0.61; P < 0.001). IL-6 levels were associated with liver disease severity assessed by Child-Pugh score(P = 0.001). This association remained significant after adjusting for nutritional status in a linear regression model. CONCLUSION: High IL-6 levels were found in children with chronic liver disease at nutritional risk. Inflammatory activity may be related to nutritional status deterioration in these patients.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第29期8927-8934,共8页 世界胃肠病学杂志(英文版)
基金 Supported by Fundo de Incentivo a Pesquisa(FIPE),Hospital de Clinicas de Porto Alegre,Post-Graduate Program of Child and Adolescent Health-UFRGS and Conselho Nacional de Desenvolvimento Cientifico e Tecnológico(CNPq),Brazil
关键词 CYTOKINES INTERLEUKIN-6 MALNUTRITION CIRRHOSIS CHILD Cytokines Interleukin-6 Malnutrition Cirrhosis Child
  • 相关文献

参考文献47

  • 1Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet2009; 374: 1704-1713 [PMID: 19914515 DOI: 10.1016/S0140-6736(09)60946-6].
  • 2Jimenez-Rivera C, Jolin-Dahel KS, Fortinsky KJ, Gozdyra P,Benchimol EI. International incidence and outcomes of biliaryatresia. J Pediatr Gastroenterol Nutr 2013; 56: 344-354 [PMID:23263590 DOI: 10.1097/MPG.0b013e318282a913].
  • 3Santos JL, Carvalho E, Bezerra JA. Advances in biliary atresia:from patient care to research. Braz J Med Biol Res 2010; 43:522-527 [PMID: 20464347].
  • 4Carvalho Ed, Santos JL, Silveira TR, Kieling CO, Silva LR,Porta G, Miura IK, De Tommaso AM, Brand-o M-, FerreiraAR, Macêdo JR, Almeida Neto JT. Biliary atresia: the Brazilianexperience. J Pediatr (Rio J) 2010; 86: 473-479 [PMID: 21140036DOI: 10.2223/jped.2054].
  • 5Suchy FJ. Neonatal cholestasis. Pediatr Rev 2004; 25: 388-396[PMID: 15520084 DOI: 10.1542/pir.25-11-388].
  • 6Davenport M. Biliary atresia: clinical aspects. Semin Pediatr Surg2012; 21: 175-184 [PMID: 22800970 DOI: 10.1053/j.sempedsurg.2012.05.010].
  • 7Kelly DA, Davenport M. Current management of biliary atresia.Arch Dis Child 2007; 92: 1132-1135 [PMID: 17878208 DOI:10.1136/adc.2006.101451].
  • 8Shneider BL, Abel B, Haber B, Karpen SJ, Magee JC, RomeroR, Schwarz K, Bass LM, Kerkar N, Miethke AG, Rosenthal P,Turmelle Y, Robuck PR, Sokol RJ. Portal hypertension in childrenand young adults with biliary atresia. J Pediatr GastroenterolNutr 2012; 55: 567-573 [PMID: 22903006 DOI: 10.1097/MPG.0b013e31826eb0cf].
  • 9Tsouka A, McLin VA. Complications of chronic liver disease. ClinRes Hepatol Gastroenterol 2012; 36: 262-267 [PMID: 22521556DOI: 10.1016/j.clinre.2012.03.015].
  • 10Utterson EC, Shepherd RW, Sokol RJ, Bucuvalas J, MageeJC, McDiarmid SV, Anand R. Biliary atresia: clinical profiles,risk factors, and outcomes of 755 patients listed for livertransplantation. J Pediatr 2005; 147: 180-185 [PMID: 16126046DOI: 10.1016/j.jpeds.2005.04.073].

同被引文献6

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部